Since mTOR inhibitors can cause interstitial pneumonitis and lead to ground glass opacity abnormality in chest CT scan (71), switching mTOR inhibitor to CNI should be considered among COVID-19 SOT patients with typical ground opacity chest CT scan. This evidence concerns the gene MTOR and COVID-19.